T. Rowe Price Associates, Inc. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 9,879,250 14.500% | 3,330,320 (+50.85%) | Filing |
| 2024-04-10 12:58 pm Purchase | 2024-03-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 6,548,930 10.700% | 693,305 (+11.84%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,855,625 9.900% | 790,881 (+15.62%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,064,744 9.200% | -803,894 (-13.70%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,868,638 12.500% | 799,188 (+15.76%) | Filing |
| 2021-07-12 2:57 pm Purchase | 2021-06-30 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,069,450 10.800% | 2,443,759 (+93.07%) | Filing |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 2,625,691 5.700% | 2,625,691 (New Position) | Filing |